Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

被引：0
|
作者：
Michele Kohli
Donna Lawrence
Jennifer Haig
Andrea Anonychuk
Nadia Demarteau
机构：
[1] OptumInsight,
[2] Health Economics and Outcomes Research,undefined
[3] GlaxoSmithKline Biologicals,undefined
[4] Global Vaccines Development,undefined
来源：
BMC Public Health | / 12卷
关键词：
Human papillomavirus; Cervical cancer; Vaccine; Cost-effectiveness; Markov model; Canada;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    DRUGS IN R&D, 2012, 12 (04) : 235 - 238
  • [32] Human papillomavirus types 16 and 18 vaccine (Recombinant, AS04 adjuvanted, adsorbed) [Cervarix™]
    Keam, Susan J.
    Harper, Diane M.
    DRUGS, 2008, 68 (03) : 359 - 372
  • [33] Human papillomavirus types 16 and 18 vaccine (Recombinant, AS04 adjuvanted, adsorbed) [Cervarix™]
    Keam, Susan J.
    Harper, Diane M.
    BIODRUGS, 2008, 22 (03) : 205 - 208
  • [34] Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted Adsorbed) [Cervarix™]
    Susan J. Keam
    Diane M. Harper
    Drugs, 2008, 68 : 359 - 372
  • [35] Bivalent Human Papillomavirus (HPV) Vaccine Effectiveness Correlates With Phylogenetic Distance From HPV Vaccine Types 16 and 18
    Bogaards, Johannes A.
    Van Der Weele, Pascal
    Woestenberg, Petra J.
    Van Benthem, Birgit H. B.
    King, Audrey J.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (07): : 1141 - 1146
  • [36] Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: Randomized study in healthy girls
    Schmeink, Channa E.
    Bekkers, Ruud L. M.
    Josefsson, Ann
    Richardus, Jan H.
    Blom, Katarina Berndtsson
    David, Marie-Pierre
    Dobbelaere, Kurt
    Descamps, Dominique
    VACCINE, 2011, 29 (49) : 9276 - 9283
  • [37] Randomized Trial: Immunogenicity and Safety of Coadministered Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine and Combined Hepatitis A and B Vaccine in Girls
    Pedersen, Court
    Breindahl, Morten
    Aggarwal, Naresh
    Berglund, Johan
    Oroszlan, Gyoergy
    Silfverdal, Sven Arne
    Szuts, Peter
    O'Mahony, Michael
    David, Marie-Pierre
    Dobbelaere, Kurt
    Dubin, Gary
    Descamps, Dominique
    JOURNAL OF ADOLESCENT HEALTH, 2012, 50 (01) : 38 - 46
  • [38] Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
    Zoltán Vokó
    László Nagyjánosi
    Zoltán Kaló
    BMC Public Health, 12
  • [39] Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer screening in Hungary
    Voko, Zoltan
    Nagyjanosi, Laszlo
    Kalo, Zoltan
    BMC PUBLIC HEALTH, 2012, 12
  • [40] Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years
    Einstein, Mark H.
    Baron, Mira
    Levin, Myron J.
    Chatterjee, Archana
    Fox, Bradley
    Scholar, Sofia
    Rosen, Jeffrey
    Chakhtoura, Nahida
    Lebacq, Marie
    van der Most, Robbert
    Moris, Philippe
    Giannini, Sandra L.
    Schuind, Anne
    Datta, Sanjoy K.
    Descamps, Dominique
    HUMAN VACCINES, 2011, 7 (12): : 1359 - 1373
12345